Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Daily News

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Michael O'Riordan

October 17, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Industry News

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

April 28, 2016

News Industry News

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

April 04, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Daily News

Years Later, Myxo Ring Controversy Heads to Courts, Taking on Northwestern Memorial and Star CV Surgeon

Shelley Wood

February 11, 2016

News Industry News

New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

November 08, 2015

News Industry News

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

September 28, 2015

News Industry News

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

August 31, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Years Later, Myxo Ring Controversy Heads to Courts, Taking on Northwestern Memorial and Star CV Surgeon

New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Primed Mesenchymal Stem Cells May Improve Heart Function

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content